CYP2D6 polymorphisms influence tamoxifen treatment outcomes in
Por um escritor misterioso
Descrição
CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis
Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer, Egyptian Journal of Medical Human Genetics
JPM, Free Full-Text
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen, Breast Cancer Research
Genes, Free Full-Text
The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer
Full article: Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment
Frontiers Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer, Egyptian Journal of Medical Human Genetics
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations - Province - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)
